The Growing US P2Y12 Inhibitors Market Shaped by Increasing Cardiovascular Procedures

 
US P2Y12 Inhibitors Market

The US P2Y12 inhibitors market is an integral part of the cardiovascular therapeutics segment. P2Y12 inhibitors, commonly known as antiplatelet drugs, play a key role in preventing blood clots and reducing ischemic events in patients undergoing angioplasty or stenting procedures. These drugs work by selectively and reversibly blocking the adenosine diphosphate receptor P2Y12 found on platelet surfaces, thereby hampering platelet activation and aggregation. Wide usage of P2Y12 inhibitors for post cardiovascular intervention, rapid revascularization, and reducing cardiovascular mortality has boosted the US market.


The Global US P2Y12 inhibitors Market is estimated to be valued at US$ 267.73 Mn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2030.

Key Takeaways
Key players operating in the US P2Y12 inhibitors are Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation.

The growing demand for P2Y12 inhibitors is attributed to the rise in cardiovascular disorders within the United States. Also, the increasing geriatric population which is more prone to heart ailments has further augmented the need for P2Y12 inhibitors.

North America dominates the Global P2Y12 Inhibitors Market Share owing to the rising prevalence of coronary artery diseases in the region. Additionally, the availability of advanced cardiac facilities and favorable reimbursement policies are fueling the market growth.

Market Key Trends
One of the key trends witnessed in the US P2Y12 inhibitors market is the growing adoption of novel oral antiplatelet drugs over traditional ones. While clopidogrel was the dominant oral drug till some years back, newer agents like ticagrelor and cangrelor have gained significant popularity in recent times owing to their improved efficacy and reduced side effects. This shift towards novel oral drugs has positively impacted the overall market revenues.

Porter’s Analysis
Threat of new entrants: The U.S. P2Y12 inhibitors market requires high R&D investments and regulatory approvals pose a barrier to entry.

Bargaining power of buyers: Large pharmaceutical companies have significant bargaining power over smaller buyers in this market.

Bargaining power of suppliers: The presence of several ingredient suppliers limits the bargaining power of individual suppliers in this market.

Threat of new substitutes: Drugs targeting other pathways have emerged as substitutes for P2Y12 inhibitors to some extent.

Competitive rivalry: Major companies aggressively compete to gain market share in this market.

Geographical Regions
The Northeast region accounts for the largest share of the U.S. P2Y12 inhibitors market in terms of value due to a high number of pharmaceutical companies and research organizations located in states like New Jersey and Pennsylvania.

The Western region is expected to grow at the fastest pace during the forecast period. This can be attributed to expansion strategies adopted by major players and increasing research initiatives in states like California and Washington.

For more details on the report, Read- https://www.rapidwebwire.com/u-s-p2y12-inhibitors-market-demand-share-analysis/

Comments

Post a Comment

Popular posts from this blog

The Notchback Market is Estimated To Witness High Growth Owing To Rising Demand From Emerging Economies

Image
  Notchback Market Market Overview: A notchback is a body style of cars characterized by a gently sloped rear window and greenhouse. Notchbacks provide practical interior space with good cargo capacity. They offer balanced interior volume for passengers and cargo along with sleek and stylish exterior design. The body style has advantages like no C-pillar which enhances visibility compared to sedans. Market key trends: The growth of the notchback market is attributed to rising demand from emerging economies like China, India and Brazil. These nations have growing middle-class population and increasing disposable income which is driving vehicle ownership. Moreover, notchback body style is quite popular in these developing markets due to its spacious cabin combined with stylish looks at affordable prices. Leading automakers are launching various notchback models to cater to the surging demand from developing countries, which is fueling the growth of the notchback market size during ...
Read more

The increasing demand for adhesives and sealants is anticipated to open up the new avenue for Petroleum Resins Market

Image
Petroleum Resins Market  Market Overview: Petroleum resins are amorphous thermoplastic polymers made from petroleum-based feedstock materials, through either thermal or catalytic polymerization. They are mainly used for applications such as adhesives, inks, paints, rubber compounding, and others. Different types of petroleum resins include C5 resins, C9 resins, hydrogenated hydrocarbons (HHCs), and modified and specialized petroleum resins. Among applications, adhesives and sealants hold the largest share in the petroleum resins market owing to increasing use of petroleum resins in hot melt and pressure sensitive adhesives. Market Dynamics: The increasing demand for adhesives from packaging and construction industries is a major driver for the petroleum resins market. According to statsista, the global adhesive market was valued at over US$ 53.3 billion in 2020 and is projected to reach around US$ 78 billion by 2027, growing at a CAGR of over 5.7% during the forecast period. Pe...
Read more

Global Synthetic Biology Market Analysis: Size and Share

Image
Synthetic Biology Market  Synthetic biology encompasses the design, construction, and redesigning of biological parts, devices, and systems, either non-existent in nature or reengineered from existing biological systems. The market is experiencing significant growth, driven by the increasing demand for personalized medicine and healthcare. Applications of synthetic biology span pharmaceuticals, chemical production, agriculture, environmental protection, and renewable energy. Advancements in synthetic biology contribute to the rapid manufacturing of biotherapeutics, fostering the development of personalized medicine and more cost-effective healthcare solutions. The Synthetic Biology Market is projected to be valued at US$ 31,693.59 million in 2023, with an expected CAGR of 28% during the forecast period from 2023 to 2030, according to a newly published report by Coherent Market Insights. Key Market Trends: A prominent trend in the Global Synthetic Biology Market is the escalat...
Read more